Literature DB >> 18617735

Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.

Toshiyuki Watanabe1, Akihiko Shiino, Ichiro Akiguchi.   

Abstract

BACKGROUND/AIMS: Although many proton magnetic resonance spectroscopy studies have assessed the relative ratios of brain metabolites from patients with dementia, absolute quantification is rare. The aim of this study is to compare the diagnostic accuracy of these 2 methods in proton magnetic resonance spectroscopy in discriminating Alzheimer's disease (AD) and Binswanger's disease (BD) from healthy controls (HC).
METHODS: The subjects were 30 AD patients, 13 BD patients and 26 HC subjects. Single-voxel proton MR spectra at short echo times were acquired from 8 volumes of interest.
RESULTS: At 80% specificity, the absolute N-acetylaspartate concentration in the hippocampus was the most sensitive measure to discriminate AD from HC, and the absolute N-acetylaspartate concentration in the anterior periventricular and deep white matter to differentiate BD from HC and AD. No relative ratio using creatine as a reference had a sensitivity over 80% at 80% specificity. The cause of disparities between the 2 methods was attributed to fluctuations in the creatine concentration.
CONCLUSION: Our study revealed that absolute quantification is superior to relative ratio to differentiate AD and BD from HC. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617735     DOI: 10.1159/000144044

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  15 in total

1.  Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials.

Authors:  Gary A Rosenberg; Jillian Prestopnik; John C Adair; Branko N Huisa; Janice Knoefel; Arvind Caprihan; Charles Gasparovic; Jeffrey Thompson; Erik B Erhardt; Ronald Schrader
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-01-24       Impact factor: 10.154

Review 2.  Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.

Authors:  Tao Song; Xiaopeng Song; Chenyawen Zhu; Regan Patrick; Miranda Skurla; Isabella Santangelo; Morgan Green; David Harper; Boyu Ren; Brent P Forester; Dost Öngür; Fei Du
Journal:  Ageing Res Rev       Date:  2021-10-29       Impact factor: 10.895

3.  Brain neurometabolites differences in individuals with subjective cognitive decline plus: a quantitative single- and multi-voxel proton magnetic resonance spectroscopy study.

Authors:  Zhongxian Yang; Xing Wan; Xinzhu Zhao; Yu Rong; Yi Wu; Zhen Cao; Qiuxia Xie; Min Luo; Yubao Liu
Journal:  Quant Imaging Med Surg       Date:  2021-09

4.  Quantitative proton magnetic resonance spectroscopy detects abnormalities in dorsolateral prefrontal cortex and motor cortex of patients with frontotemporal lobar degeneration.

Authors:  Sanjeev Chawla; Sumei Wang; Peachie Moore; John H Woo; Lauren Elman; Leo F McCluskey; Elias R Melhem; Murray Grossman; Harish Poptani
Journal:  J Neurol       Date:  2009-08-18       Impact factor: 4.849

5.  1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.

Authors:  Charles Gasparovic; Jillian Prestopnik; Jeffrey Thompson; Saeid Taheri; Branko Huisa; Ronald Schrader; John C Adair; Gary A Rosenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-02-16       Impact factor: 10.154

Review 6.  Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease.

Authors:  Ningnannan Zhang; Xiaowei Song; Robert Bartha; Steven Beyea; Ryan D'Arcy; Yunting Zhang; Kenneth Rockwood
Journal:  Curr Alzheimer Res       Date:  2014-05       Impact factor: 3.498

7.  Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.

Authors:  Aisling M Chaney; Francisco R Lopez-Picon; Sophie Serrière; Rui Wang; Daniela Bochicchio; Samuel D Webb; Matthias Vandesquille; Michael K Harte; Christina Georgiadou; Catherine Lawrence; Julie Busson; Johnny Vercouillie; Clovis Tauber; Frédéric Buron; Sylvain Routier; Tristan Reekie; Anniina Snellman; Michael Kassiou; Johanna Rokka; Karen E Davies; Juha O Rinne; Dervis A Salih; Frances A Edwards; Llwyd D Orton; Stephen R Williams; Sylvie Chalon; Hervé Boutin
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

8.  An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease.

Authors:  Marc L Gordon; Peter B Kingsley; Terry E Goldberg; Jeremy Koppel; Erica Christen; Lynda Keehlisen; Nina Kohn; Peter Davies
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-08-16

Review 9.  Cerebral small vessel disease and Alzheimer's disease.

Authors:  Zhiyou Cai; Chuanling Wang; Wenbo He; Hanjun Tu; Zhengang Tang; Ming Xiao; Liang-Jun Yan
Journal:  Clin Interv Aging       Date:  2015-10-23       Impact factor: 4.458

10.  MRI features of Binswanger's disease predict prognosis and associated pathology.

Authors:  Ichiro Akiguchi; Herbert Budka; Yoshitomo Shirakashi; Adelheid Woehrer; Toshiyuki Watanabe; Akihiko Shiino; Yasumasa Yamamoto; Yasuhiro Kawamoto; Wolfgang Krampla; Susanne Jungwirth; Peter Fischer
Journal:  Ann Clin Transl Neurol       Date:  2014-10-06       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.